TY - JOUR
KW - Aged
KW - Analgesics, Opioid/adverse effects
KW - Codeine/adverse effects
KW - *Hip Fractures/chemically induced/drug therapy/epidemiology
KW - Humans
KW - Pain/drug therapy
KW - Quality of Life
KW - *Tramadol/adverse effects
AU - E. Voss
AU - S. Ali
AU - A. Singh
AU - P. Rijnbeek
AU - M. Schuemie
AU - D. Fife
AD - Janssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA. evoss3@its.jnj.com.
Observational Health Data Sciences and Informatics (OHDSI), OHDSI Collaborators, New York, NY, USA. evoss3@its.jnj.com.
Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. evoss3@its.jnj.com.
Janssen Research & Development LLC, 920 Route 202, Raritan, NJ, 08869, USA.
Observational Health Data Sciences and Informatics (OHDSI), OHDSI Collaborators, New York, NY, USA.
Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
AN - 35810265
BT - Drug Saf
C2 - PMC9296392 of Janssen Research and Development LLC and shareholders of Johnson & Johnson (J&J) stock. Daniel Fife, at the time of this research, was also an employee Janssen Research and Development LLC and shareholder of J&J stock; however, he has since retired. Peter R. Rijnbeek is an employee of an institution that receives/received research grants from Janssen Research and Development LLC. J&J subsidiary companies market both tramadol-containing and codeine-containing products.
DO - 10.1007/s40264-022-01198-9
DP - NLM
ET - 2022/07/10
LA - eng
M1 - 7
N1 - 1179-1942
Voss, Erica A
Orcid: 0000-0002-0651-0613
Ali, Saberi Rana
Singh, Arun
Orcid: 0000-0002-9567-6139
Rijnbeek, Peter R
Schuemie, Martijn J
Orcid: 0000-0002-0817-5361
Fife, Daniel
Journal Article
Observational Study
Drug Saf. 2022 Jul;45(7):791-807. doi: 10.1007/s40264-022-01198-9. Epub 2022 Jul 9.
PY - 2022
SN - 0114-5916 (Print)
0114-5916
SP - 791
EP - 807
T2 - Drug Saf
TI - Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study
VL - 45
ER -